BioXcel Therapeutics, Inc. (BTAI)

BioXcel Therapeutics Revenue

BioXcel Therapeutics had revenue of $214.00K in the quarter ending September 30, 2024, a decrease of -37.24%. This brings the company's revenue in the last twelve months to $2.28M, up 83.25% year-over-year. In the year 2023, BioXcel Therapeutics had annual revenue of $1.38M with 268.00% growth.

• Revenue (ttm): $2.28M
• Revenue Growth: +83.25%
• P/S Ratio: 9.24
• Revenue / Employee: $30,757
• Employees: 74
• Market Cap: 23.15M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.38M	1.01M	268.00%
Dec 31, 2022	375.00K	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.